Segui
Megan B. Murray
Megan B. Murray
Harvard Medical School
Email verificata su hms.harvard.edu
Titolo
Citata da
Citata da
Anno
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies
CY Jeon, MB Murray
PLoS medicine 5 (7), e152, 2008
20032008
Transmission dynamics and control of severe acute respiratory syndrome
M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ...
science 300 (5627), 1966-1970, 2003
18502003
The impact of diabetes on tuberculosis treatment outcomes: a systematic review
MA Baker, AD Harries, CY Jeon, JE Hart, A Kapur, K Lönnroth, ...
BMC medicine 9, 1-15, 2011
10022011
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis
HH Lin, M Ezzati, M Murray
PLoS medicine 4 (1), e20, 2007
9802007
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
6912017
Tuberculosis drug resistance mutation database
A Sandgren, M Strong, P Muthukrishnan, BK Weiner, GM Church, ...
PLoS medicine 6 (2), e1000002, 2009
6542009
The adverse effect of iron repletion on the course of certain infections.
MJ Murray, AB Murray, MB Murray, CJ Murray
Br Med J 2 (6145), 1113-1115, 1978
5701978
The adverse effect of iron repletion on the course of certain infections.
CJM MJ Murray, AB Murray, MB Murray
British Medical Journal 2, 1113-1115, 1978
5701978
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
MH Hazbón, M Brimacombe, M Bobadilla del Valle, M Cavatore, ...
Antimicrobial agents and chemotherapy 50 (8), 2640-2649, 2006
5472006
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
5052013
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
5002013
Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production
C Colijn, A Brandes, J Zucker, DS Lun, B Weiner, MR Farhat, TY Cheng, ...
PLoS computational biology 5 (8), e1000489, 2009
4592009
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
T Cohen, M Murray
Nature medicine 10 (10), 1117-1121, 2004
3942004
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
3532014
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis
KR Jacobson, DB Tierney, CY Jeon, CD Mitnick, MB Murray
Clinical infectious diseases 51 (1), 6-14, 2010
3472010
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
HH Lin, M Murray, T Cohen, C Colijn, M Ezzati
The Lancet 372 (9648), 1473-1483, 2008
3432008
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
3412017
Genotypic Analysis of Mycobacterium tuberculosis in Two Distinct Populations Using Molecular Beacons: Implications for Rapid Susceptibility Testing
AS Piatek, A Telenti, MR Murray, H El-Hajj, WR Jacobs Jr, FR Kramer, ...
Antimicrobial agents and chemotherapy 44 (1), 103-110, 2000
3372000
Tuberculosis and poverty: why are the poor at greater risk in India?
O Oxlade, M Murray
PloS one 7 (11), e47533, 2012
3202012
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3172018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20